DIA 2023: Understanding eConsent
In an interview at the 2023 DIA annual meeting with ACT editor, Andy Studna, Hilde Vanaken, PhD, head, European Forum GCP (EFGCP) eConsent Initiative, and head, TCS Industry Leaders discusses what eConsent is all about and common misunderstandings surrounding it. She also touches on an article she recently authored for Applied Clinical Trials on eConsent which can be found here.
SCOPE 2024: Todd Everhart of Signant Health Discusses DCTs and Site Burden
February 13th 2024In an interview with ACT editor Andy Studna at SCOPE, Everhart, MD, FACP, clinical vice president, internal medicine, Signant Health discusses decentralized trials and how they may be increasing site burden.
SCOPE 2024: Wendy Morahan of IQVIA Discusses the Use of AI in Clinical Trials
February 13th 2024In an interview with ACT editor Andy Studna at SCOPE, Morahan, senior director, clinical data analytics, IQVIA Technologies discusses how AI can advance trial execution and what stakeholders should be keeping top of mind when choosing technology vendors.
